(NASDAQ: CODX) Co Diagnostics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.07%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.79%.
Co Diagnostics's earnings in 2026 is -$47,475,957.On average, 3 Wall Street analysts forecast CODX's earnings for 2026 to be -$33,239,545, with the lowest CODX earnings forecast at -$31,936,033, and the highest CODX earnings forecast at -$34,217,178. On average, 3 Wall Street analysts forecast CODX's earnings for 2027 to be -$889,962,005, with the lowest CODX earnings forecast at -$855,061,535, and the highest CODX earnings forecast at -$916,137,359.
In 2028, CODX is forecast to generate -$3,002,281 in earnings, with the lowest earnings forecast at -$2,884,545 and the highest earnings forecast at -$3,090,584.